Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study.

Autor: Sierro TJ; University of Southern California Keck School of Medicine, Los Angeles, California., Blumenthal LY; Center for Dermatology Care, Thousand Oaks, California., Hekmatjah J; University of Southern California Keck School of Medicine, Los Angeles, California., Chat VS; University of Southern California Keck School of Medicine, Los Angeles, California., Kassardjian AA; University of Southern California Keck School of Medicine, Los Angeles, California., Read C; University of Southern California Keck School of Medicine, Los Angeles, California; Department of Medicine, Imperial College London, London, United Kingdom., Armstrong AW; University of Southern California Keck School of Medicine, Los Angeles, California. Electronic address: armstrongpublication@gmail.com.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Feb; Vol. 86 (2), pp. 373-378. Date of Electronic Publication: 2021 Jul 09.
DOI: 10.1016/j.jaad.2021.07.005
Abstrakt: Background: As the United States becomes more diverse, determining differences in health care utilization and costs in the management of skin cancers is fundamental to decision-making in health care resource allocation and improving care for underserved populations.
Objective: To compare health care use and costs among non-Hispanic White, Hispanic White, and non-Hispanic Black patients with keratinocyte carcinoma.
Methods: A nationwide cross-sectional study was performed using Medical Expenditure Panel Survey data from 1996 to 2015.
Results: Among 54,503,447 patients with keratinocyte carcinoma (weighted) over a 20-year period, 53,134,351 (97%) were non-Hispanic White; 836,030 (1.5%) were Hispanic White; and 170,755 (0.3%) were non-Hispanic Black. Compared to non-Hispanic White patients, Hispanic White patients had significantly more ambulatory visits per person per year (5.4 vs 3.5, P = .003). Compared to non-Hispanic White patients, non-Hispanic Black patients had significantly more ambulatory visits (13.1 vs 3.5, P = .027) and emergency department visits (2.3 vs 1.1, P < .001), and incurred significantly higher ambulatory costs ($5089 vs $1131, P = .05), medication costs ($523 vs $221, P = .022), and total costs per person per year ($13,430 vs $1290, P = .032).
Limitations: Data for squamous cell carcinomas and basal cell carcinomas are combined.
Conclusions: Keratinocyte carcinoma was more costly to treat and required more health care resources in non-Hispanic Black and Hispanic White patients than in non-Hispanic White patients.
Competing Interests: Conflicts of interest Dr Armstrong serves as a research investigator and/or scientific advisor to AbbVie, BMS, Incyte, Leo, UCB, Janssen, Lilly, Novartis, Ortho Dermatologics, Sun, Dermavant, Dermira, Sanofi, Regeneron, Pfizer, and Modmed. Drs Sierro, Blumenthal, Hekmatjah, Chat, Kassardjian, and Read have no conflicts of interest to declare relevant to this manuscript.
(Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: